We measured NAB to IFN‐α, ‐β, and ‐ω in the supernatants of respiratory samples (nasopharyngeal swabs [NPS] (n = 6) and bronchoalveolar lavage [BAL] [n = 11]) collected from 17 COVID‐19 patients for whom paired serum samples were available (Supporting information Table S2). This evidence concerns the gene IFNA2 and COVID-19.